Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis (Q33914734)

30 July 2017

Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis (English)

1 reference

30 July 2017

1 reference

Ballot E

1

1 reference

PubMed ID

10952238

30 July 2017

Homberg JC

series ordinal

2

1 reference

PubMed ID

10952238

30 July 2017

Johanet C

series ordinal

3

1 reference

30 July 2017

1 August 2000

1 reference

30 July 2017

Journal of Hepatology

1 reference

30 July 2017

33

1 reference

30 July 2017

2

1 reference

30 July 2017

208-215

1 reference

Meeting report: International Autoimmune Hepatitis Group

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Liver/kidney microsome antibody type 1 and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Glutathione S-transferase as a major autoantigen in anti-SLA-positive autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

1 reference

7 January 2021

Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Antibodies to P450IID6, SLA, PDH-E2 and BCKD-E2 in Japanese patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

The natural course and heterogeneity of autoimmune-type chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

The nature and prognosis of severe cryptogenic chronic active hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Characteristics of clometacin-induced hepatitis with special reference to the presence of anti-actin cable antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

Anti-actin autoantibodies in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980361-X

7 January 2021

10.1016/S0168-8278(00)80361-X

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10952238